Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome. - Wikidata - awgldk - TriplyDB

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

http://www.wikidata.org/entity/Q54489448

about

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome Advances and challenges in the management of complement-mediated thrombotic microangiopathies Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic Syndrome Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment.Acute Kidney Injury in Pregnancy.Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.Hemolytic Uremic Syndrome in Pregnancy and Postpartum.

P2860

Q26750692-AE7BBAF3-1B91-4EA7-B094-30F29FC44C59 Q26796453-BEA24BB9-40DD-4164-A616-5ACEE3D48680 Q33430320-15582A2C-7A4F-4DDE-99A8-137726CB7ABA Q33437634-89D7688C-6803-4861-B9A9-DE2B972445B6 Q33439152-D8D24D06-4ECA-4A3E-B68D-0208BFC04EE8 Q33705135-EE87D6DD-4F02-4AB4-9335-86649DAE1D5A Q33783126-796CB3E8-4F97-465A-8C24-18EFB1153DE5 Q37563002-1B8D25C1-6F0A-4E40-AFC6-CF75DF2C8916 Q39436556-8BD390D5-9E14-4636-BE77-47BBBF20DC1E Q47251151-84AA184A-2581-48BF-A2B6-3BB7FC86D7CF Q47736433-1988C734-56E1-4984-BCEE-CB9AD50D5513

P2860

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

http://www.wikidata.org/entity/Q54489448

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

@en

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

@nl

type

label

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

@en

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

@nl

prefLabel

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

@en

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

@nl

P1433

Q54489448-55CA243C-8229-47BA-9CCB-E817CFB247E5

P1476

Q54489448-F16C54AB-1E49-411B-8D93-5BFDCC59E9F2

P2093

Q54489448-04801F6E-823A-4043-A291-834DBB35C62B

Q54489448-2F00FEA3-8BE7-47D5-A027-C7F36DED6755

Q54489448-635A01F4-DEDA-4B41-B9A7-2703BA8E33B2

Q54489448-79FE0779-D9BA-4CF9-B381-E31C621DC24B

Q54489448-A0203B84-FCF5-41F1-95F5-6A7C0E7B9111

Q54489448-A1B65935-FA9C-4A63-BAF6-BAB93C65201A

Q54489448-B8164786-64F0-4226-861F-8E1AEE8FB56A

P2860

Q54489448-3E1C5922-33EB-46B8-A1C1-2DF456F787A7

Q54489448-514331E9-7464-40CB-8E20-6CA19586A972

Q54489448-5839B1BF-4CAB-4BDE-BAE0-680A3E6DAF1C

Q54489448-71802E59-6372-4F49-9BA4-F69DA96C4F7D

Q54489448-8F7B2F5F-ADEF-4A1F-9E7C-007EA4F6C327

Q54489448-A1652C83-9E79-474D-8619-40479310A4FD

Q54489448-ECA2667C-2708-4223-BA0A-B9B3F007967E

Q54489448-F4615B50-B8E8-4D39-B255-F183D0B33A9D

P304

Q54489448-5A81E482-6E22-4415-972C-6D098EF6D13D

P31

Q54489448-5B33BB6B-6107-4D66-B78D-D4D91DC3EBDE

P356

Q54489448-2B9278E2-ED9C-40F1-A5F6-7533C6112B7C

P433

Q54489448-0EDCAE6D-71B9-4D4D-BAB8-5E790D2973C0

P478

Q54489448-9334CDB5-AE6B-4375-9CBB-ED96E9D422FC

P50

Q54489448-4DC6360E-2CB9-4D43-B83E-334DF69D5D02

Q54489448-E0E0D76E-F955-4FBC-80B7-D44041C1B861

P577

Q54489448-62748A26-9CF3-44A6-9948-22B046B1CF51

P698

Q54489448-4D387DE0-FED1-43B8-AE20-0914D88FCE5F

P356

S00277-013-1970-3

P1433

Annals of Hematology

P1476

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

@en

P2093

Aima Lancharro

http://www.w3.org/2001/XMLSchema#string

Azucena Pajares

http://www.w3.org/2001/XMLSchema#string

Carolina Cañigral

http://www.w3.org/2001/XMLSchema#string

Cristina Castro

http://www.w3.org/2001/XMLSchema#string

Federico Moscardó

http://www.w3.org/2001/XMLSchema#string

Nelly Carpio

http://www.w3.org/2001/XMLSchema#string

Pilar Solves

http://www.w3.org/2001/XMLSchema#string

P2860

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.

Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.

Atypical hemolytic-uremic syndrome.

Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

Plasmatherapy in atypical hemolytic uremic syndrome.

Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.

Hemolytic Uremic Syndrome

P304

1421-1422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-013-1970-3

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P50

Javier de la Rubia

P577

2013-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24306089

http://www.w3.org/2001/XMLSchema#string